Featured Research

from universities, journals, and other organizations

Could sticky cells cause drug resistance in chronic blood cancer?

Date:
March 10, 2014
Source:
Manchester University
Summary:
Chronic myeloid leukaemia (CML) is associated with a specific genetic mutation that results from DNA on different chromosomes breaking off and swapping places. This disrupts genes at the breakpoint and the rejoining point. One of these disrupted genes is called BCR-ABL and drugs that target this mutation have transformed the treatment of CML. However, patients can develop resistance to these drugs, which causes their cancer to return. Now scientists have measured the levels of the BCR-ABL genetic mutation in a cell model of CML. In particular, they separated cells into those that stuck to plastic – “sticky”, or adherent, cells – and those non-adherent ones that did not, and looked for differences between the two groups of cells.

Researchers in Manchester have investigated the stickiness of leukemia cells, and whether this is linked to drug resistance.

Related Articles


Chronic myeloid leukemia (CML) is associated with a specific genetic mutation that results from DNA on different chromosomes breaking off and swapping places. This disrupts genes at the breakpoint and the rejoining point. One of these disrupted genes is called BCR-ABL and drugs that target this mutation have transformed the treatment of CML. However, patients can develop resistance to these drugs, which causes their cancer to return.

Now scientists from The University of Manchester -- part of the Manchester Cancer Research Centre -- have measured the levels of the BCR-ABL genetic mutation in a cell model of CML. In particular, they separated cells into those that stuck to plastic -- "sticky," or adherent, cells -- and those non-adherent ones that did not, and looked for differences between the two groups of cells.

Dr Richard Byers, who jointly led the research, said: "Previous studies have linked high levels of the BCR-ABL mutation with drug resistance. We wanted to see how expression of BCR-ABL differed across groups of CML cells, and in particular whether there were differences between adherent and non-adherent populations."

In a study recently published in the journal Experimental Haematology, the group demonstrate that is wide variation in BCR-ABL expression levels in the cell model and the stickier cells have a higher level of BCR-ABL expression. These stickier cells were less sensitive to treatment with a BCR-ABL targeted drug, imatinib.

Dr Byers said: "The small number of cells that show high levels of BCR-ABL may not be detectable through bulk analysis of large samples.

"It looks like it is important to look at protein levels in single cells. In future, it may be possible to measure BCR-ABL levels in individual cells in the clinic -- this will help us identify the resistant high BCR-ABL cells and better understand how patients develop resistance to imatinib treatment with the aim of combatting this resistance to make response more durable and the treatment more effective."


Story Source:

The above story is based on materials provided by Manchester University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Ehsan Ghayoor Karimiani, Fiona Marriage, Anita J. Merritt, John Burthem, Richard John Byers, Philip J.R. Day. Single-cell analysis of K562 cells: An imatinib-resistant subpopulation is adherent and has upregulated expression of BCR-ABL mRNA and protein. Experimental Hematology, 2013; DOI: 10.1016/j.exphem.2013.11.006

Cite This Page:

Manchester University. "Could sticky cells cause drug resistance in chronic blood cancer?." ScienceDaily. ScienceDaily, 10 March 2014. <www.sciencedaily.com/releases/2014/03/140310090751.htm>.
Manchester University. (2014, March 10). Could sticky cells cause drug resistance in chronic blood cancer?. ScienceDaily. Retrieved November 21, 2014 from www.sciencedaily.com/releases/2014/03/140310090751.htm
Manchester University. "Could sticky cells cause drug resistance in chronic blood cancer?." ScienceDaily. www.sciencedaily.com/releases/2014/03/140310090751.htm (accessed November 21, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

UN Says It Will Scale Up Its Ebola Response

UN Says It Will Scale Up Its Ebola Response

AFP (Nov. 20, 2014) UN Resident Coordinator David McLachlan-Karr and WHO representative in the country Daniel Kertesz updated the media on the UN Ebola response on Wednesday. Duration: 00:51 Video provided by AFP
Powered by NewsLook.com
Takata Offers "sincerest Condolences" To Victims of Malfunctioning Airbag

Takata Offers "sincerest Condolences" To Victims of Malfunctioning Airbag

Reuters - US Online Video (Nov. 20, 2014) U.S. Congress hears from a victim and company officials as it holds a hearing on the safety of Takata airbags after reports of injuries. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
Obesity Costs Almost As Much As War And Terrorism

Obesity Costs Almost As Much As War And Terrorism

Newsy (Nov. 20, 2014) The newest estimate of the cost of obesity is pretty jarring — $2 trillion. But how did researchers get to that number? Video provided by Newsy
Powered by NewsLook.com
Calling All Men: Here's Your Chance to Experience Labor Pains

Calling All Men: Here's Your Chance to Experience Labor Pains

Reuters - Light News Video Online (Nov. 20, 2014) Chinese hospital offers men a chance to experience the pain of child birth via electric shocks. Sharon Reich reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins